Literature DB >> 20219882

Humoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccine.

Michael W Leschnik1, Georges Kirtz, Gelas Khanakah, Georg Duscher, Ernst Leidinger, Johann G Thalhammer, Anja Joachim, Gerold Stanek.   

Abstract

Lyme arthritis in dogs can be induced under experimental and natural conditions. However, the veterinary relevance of canine borreliosis is still under extensive investigation. The prevalence of symptoms is clearly low, although the risk of tick exposure is high. Current research focuses on case definitions, methods for diagnosing clinical disease in dogs, and discrimination between an immune response to a natural infection and an immune response to vaccination. In this experimental study, 23 dogs raised under tick-free conditions were allocated to two groups. The 11 dogs in the first group were vaccinated with a commercial borrelia vaccine and subsequently developed detectable antibody titers. The 12 dogs in the second group were walked on two consecutive days in an area where ticks were endemic. On day 5 after exposure, engorged ticks were removed from the 12 dogs and were analyzed for Borrelia DNA by a real-time PCR assay. Blood samples were taken before exposure/vaccination and at defined time points thereafter. Antibody responses were evaluated using an immunofluorescence antibody test (IFAT) and Western blotting. Seven dogs from which Borrelia-positive ticks were removed seroconverted and developed individual immune responses. Blood and urine samples taken from the tick-exposed group at weeks 1 and 3 for real-time PCR analysis and culture were always negative for bacterial DNA. In conclusion, despite serological evidence of infection/immunization, no clinical signs of disease were observed. The antibody patterns in a single Western blot did not permit differentiation between the different antigen sources (vaccine versus natural infection). However, repeated Western blot analyses may be useful for the confirmation of infection or vaccination status, since the time courses of the levels of specific antibodies seem to be different.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219882      PMCID: PMC2863390          DOI: 10.1128/CVI.00427-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  32 in total

1.  A serological study of cohorts of young dogs, naturally exposed to Ixodes ricinus ticks, indicates seasonal reinfection by Borrelia burgdorferi sensu lato.

Authors:  K E Hovius; S G Rijpkema; P Westers; B A van der Zeijst; F J van Asten; D J Houwers
Journal:  Vet Q       Date:  1999-01       Impact factor: 3.320

2.  Cross-reactive proteins of Borrelia burgdorferi.

Authors:  H R Bruckbauer; V Preac-Mursic; R Fuchs; B Wilske
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

3.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 4.  Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs.

Authors:  R H Jacobson; Y F Chang; S J Shin
Journal:  Semin Vet Med Surg (Small Anim)       Date:  1996-08

5.  Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis.

Authors:  S A Levy; L A Magnarelli
Journal:  J Am Vet Med Assoc       Date:  1992-02-01       Impact factor: 1.936

Review 6.  Canine borreliosis.

Authors:  Meryl P Littman
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-07       Impact factor: 2.093

7.  Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi.

Authors:  Steven Levy; Thomas P O'Connor; Jancy L Hanscom; Paulette Shields
Journal:  Vet Ther       Date:  2002

8.  [Incidence of antibodies to Borrelia burgdorferi in dogs in small animal practice in North Bavaria].

Authors:  A Weber; U Heim; R Schäfer
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1991-11-01       Impact factor: 0.328

9.  Detection of Borrelia burgdorferi in urine specimens from dogs by a nested polymerase chain reaction.

Authors:  R Bauerfeind; U Kreis; R Weiss; L H Wieler; G Baljer
Journal:  Zentralbl Bakteriol       Date:  1998-05

10.  Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.

Authors:  S W Barthold; S A Levy; E Fikrig; L K Bockenstedt; A L Smith
Journal:  J Am Vet Med Assoc       Date:  1995-12-01       Impact factor: 1.936

View more
  4 in total

1.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Wildlife reservoirs for vector-borne canine, feline and zoonotic infections in Austria.

Authors:  Georg G Duscher; Michael Leschnik; Hans-Peter Fuehrer; Anja Joachim
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-12-12       Impact factor: 2.674

3.  Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.

Authors:  Christina M Small; Dharani K Ajithdoss; Aline Rodrigues Hoffmann; Waithaka Mwangi; Maria D Esteve-Gassent
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

4.  Effect of owner-controlled acaricidal treatment on tick infestation and immune response to tick-borne pathogens in naturally infested dogs from Eastern Austria.

Authors:  Michael Leschnik; Andrea Feiler; Georg G Duscher; Anja Joachim
Journal:  Parasit Vectors       Date:  2013-03-09       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.